A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)
Clinical trial NCT01258907 · COMPLETED
Trial details
- NCT number
- NCT01258907
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-07-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.